N-(hydroxymethyl)-2-phenylacetamide

N-(hydroxymethyl)-2-phenylacetamide is an organic compound characterized by the presence of both a hydroxymethyl group and a phenylacetamide backbone. This molecular structure imparts unique reactivity and makes it a valuable intermediate in synthetic organic chemistry. Its functional groups facilitate a variety of chemical transformations, supporting its use in research settings focused on the development of new molecules and the exploration of reaction mechanisms. The compound's versatility and stability also render it relevant for studies in medicinal chemistry, fine chemical synthesis, and structure-activity relationship investigations.

Synthetic intermediate: In organic synthesis, N-(hydroxymethyl)-2-phenylacetamide serves as a practical building block or intermediate for the preparation of structurally diverse compounds. Its hydroxymethyl functionality allows for further derivatization, such as alkylation, acylation, or oxidation, which can be leveraged to construct more complex molecular frameworks. Researchers often utilize this compound in multi-step synthetic routes where selective functional group transformations are required, thereby enabling the efficient assembly of target molecules for further study.

Medicinal chemistry research: The compound is frequently utilized in medicinal chemistry for the design and synthesis of novel analogs. Its phenylacetamide core is a privileged scaffold found in numerous bioactive molecules, and the introduction of a hydroxymethyl group can modulate physicochemical properties such as solubility and hydrogen-bonding capacity. By incorporating this compound into lead optimization programs, scientists can systematically investigate the impact of structural modifications on biological activity and pharmacokinetic profiles, advancing the understanding of structure-activity relationships.

Analytical method development: N-(hydroxymethyl)-2-phenylacetamide is employed as a reference standard or model substrate in the development and validation of analytical techniques. Its well-defined structure and stability make it suitable for use in chromatographic method optimization, including HPLC and GC analyses. By serving as a test compound, it aids in calibrating analytical instruments, assessing method sensitivity, and evaluating the efficiency of separation protocols for compounds with similar functionalities.

Chemical reactivity studies: Due to its bifunctional nature, the molecule is an effective probe in mechanistic studies examining nucleophilic substitution, condensation, and oxidation reactions. Researchers utilize it to explore the influence of substituents on reaction rates, product distributions, and selectivity. Insights gained from such investigations contribute to a deeper understanding of reaction mechanisms and inform the design of more efficient synthetic methodologies for related amide or alcohol derivatives.

Fine chemical synthesis: In the fine chemical and specialty chemical sectors, N-(hydroxymethyl)-2-phenylacetamide is incorporated into the synthesis of high-value compounds such as custom reagents, ligands, or advanced intermediates. Its compatibility with a range of functional group manipulations allows chemists to tailor its transformation toward specific end products, supporting innovation in the development of new materials, catalysts, or specialty additives. This adaptability underscores its importance as a versatile tool for both academic and industrial research applications.

1. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. High fat diet and GLP-1 drugs induce pancreatic injury in mice

5. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients